InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-39.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Haughey Thomas, 董事. Officer active across 1 company, notably ANI Pharmaceuticals INC. In total, 8 reports have been recorded. Split: 1 buy · 2 sells. Total volume traded: €1.5m. History available since 6 December 2021. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Haughey Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
4,357 股0Common StockSEC:0001272247-26-000004:0
2,000 股Common StockSEC:0001272247-26-000004:1
19,341 股@ US$85.9394.2% 占其流量Common StockSEC:0001272247-25-000005:0
4,336 股0Common StockSEC:0001272247-25-000003:0
4,410 股0Common StockSEC:0001272247-24-000003:0
6,865 股0Common StockSEC:0001104659-23-064140:0
10,049 股0Common StockSEC:0001415889-22-004401:0
2,500 股@ US$39.385.8% 占其流量Common StockSEC:0001415889-21-005743:0
标准退出：2022年3月6日 (T+90)
8 条申报中的 8 条
About Haughey Thomas
HAUGHEY THOMAS is Administrateur at ANI Pharmaceuticals INC (XNAS). Across 8 filings in total, the 8 sampled filings cover the period from 2021-12-07 to 2026-06-10, with buys of EUR 87087 and sells of EUR 1423280; the most frequent transaction nature is Attribution.
